
Robert S. Hekemian, Jr.
About Robert S. Hekemian, Jr.
Robert S. Hekemian, Jr. is Chief Executive Officer (since April 2018), President (since February 2019), and a director (since 2007) of First Real Estate Investment Trust of New Jersey, Inc. (FREIT/FREVS). He is 65, with 40+ years of real estate experience across property management, leasing, financing, construction, and acquisitions; education includes a B.S. in Business Administration (American University) and an M.S. in Management as an MIT Sloan Fellow . FREIT discloses cumulative TSR values in its pay-versus-performance table and net income trends; 2024 TSR value of $100 was $140.51, 2023 $130.77, 2022 $124.62; net income attributable to common equity was $15.9 million in FY2024, $0.8 million in FY2023, $46.0 million in FY2022 .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| FREIT (FREVS) | Director | 2007–present | Board oversight; governance continuity |
| FREIT (FREVS) | Chief Executive Officer | Apr 2018–present | Leadership transition post-chairman retirement; strategy oversight |
| FREIT (FREVS) | President | Feb 2019–present | Executive responsibility for operations |
| Hekemian & Co. | Executive Vice President | 1983–2003 | Operations and strategic property evaluation |
| Hekemian & Co. | President & COO | 2004–2020 | Operational leadership and acquisitions pipeline |
| Hekemian & Co. | Chief Executive Officer | 2021–present | Lead role at external manager to FREIT |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| Oritani Financial Corp./Oritani Bank | Director; Chair, Loan Committee | Until Dec 2019 | Oritani merged into Valley National Bancorp in 12/2019; FREIT has a Valley National mortgage loan with extensions in 2023–2025 |
| Hackensack University Medical Center | Board of Governors member | N/A | Governance in regional healthcare |
| Hackensack University Medical Center Foundation | Former Director | N/A | Prior philanthropic governance |
| New York Philharmonic | Former Board Member | N/A | Cultural institution board service |
| Bergen County Community College Foundation | Former Chairman | N/A | Education foundation leadership |
| State of New Jersey | Condemnation Commissioner | N/A | Public appointment |
| Meridian School of Medicine | Board Member; Chair, Student Affairs Committee | N/A | Academic oversight |
Fixed Compensation
| Metric | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Base Salary ($) | $500,000 | $564,888 (prorated for increase) | $600,000 |
| Bonus ($) | $0 | $0 | $0 |
| Stock Awards ($) | $0 | $20,000 (1,290 shares; 3/9/2023) | $20,000 (1,230 shares; 3/22/2024) |
| All Other Compensation ($) | $330,779 | $58,756 | $60,000 |
| Total Compensation ($) | $830,779 | $643,644 | $680,000 |
Notes:
- The Compensation Committee increased CEO base salary to $600,000 effective March 9, 2023; FY2023 reflects prorated impact .
- CEO and directors received fully vested stock awards in lieu of $20,000 cash in FY2023 and FY2024 .
Performance Compensation
| Metric | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| Incentive-based cash bonus | N/A | N/A | N/A | None; not paid in FY2024 | N/A |
| Equity awards to directors (annual) | N/A | $20,000 value | 1,290 shares (3/9/2023); 1,230 shares (3/22/2024) | Shares granted in lieu of cash director fees | Fully vested at grant |
- FREIT did not pay any incentive-based compensation to executive officers during FY2024; clawback policy adopted for any future incentive-based compensation tied to erroneous data .
Equity Ownership & Alignment
| Item | Value |
|---|---|
| Aggregate shares beneficially owned | 368,301 shares |
| Percent of class | 4.9% (based on 7,471,344 shares outstanding as of 5/20/2025) |
| Shares acquirable within 60 days | 0 |
| Pledged shares (collateral) | 78,917 shares pledged to secure indebtedness of an affiliated entity |
| Indirect holdings detail | 102,216 shares via partnerships/LLCs; 9,238 shares held in trust for his children; 11,000 shares in trusts for nephews (trustee); 25,458 shares held in a trust of which he is a beneficiary; disclaims beneficial ownership except to pecuniary interest |
Policy overlays:
- Hedging prohibited for employees/directors (puts, calls, swaps, derivatives) .
- No outstanding options at FY2024 year-end; no unvested equity awards disclosed for CEO .
Employment Terms
- No employment contracts between FREIT and executive officers; no severance or change-in-control cash arrangements for executives at the FREIT level .
- Equity Incentive Plan provides for accelerated vesting/exercisability upon “change in control” or sale of substantially all assets; awards vest terms set by Board; term up to 10 years; plan extended to 2028 .
- Deferred Fee Plan was terminated; final payments occurred Jan 20, 2023 (approx. $2.317 million cash across participants and 274,509 shares issued for vested share units) .
- FREIT is externally managed; Management Agreement with Hekemian & Co. auto-renews every two years (current term expires Oct 31, 2025). FREIT may terminate without cause on one year notice; termination fee applies; if following merger/acquisition, fee equals 2.5× the standard termination fee .
Board Governance
- Board leadership is separated: Chairman (Ronald J. Artinian) and CEO (Robert S. Hekemian, Jr.); no formal Lead Independent Director though Chairman functions informally in that role .
- Independence: 4 of 7 directors qualify as independent: Ronald J. Artinian, David F. McBride, Justin F. Meng, Richard J. Aslanian; all committee members are independent .
- Board meetings: 14 in FY2024; each director attended at least 75% of Board and committee meetings; all attended 2024 annual meeting .
Committee memberships and chairs:
| Committee | Members | Chair | Independence |
|---|---|---|---|
| Audit | Ronald J. Artinian; David F. McBride; Richard J. Aslanian | Ronald J. Artinian | All independent |
| Compensation | David F. McBride; Justin F. Meng; Richard J. Aslanian | David F. McBride | All independent |
| Nominating | David F. McBride; Richard J. Aslanian | N/A | All independent |
- Audit Committee Financial Expert: Board does not believe any member qualifies under SEC rules, though members possess relevant attributes .
Director compensation:
- FY2024: Each director received $20,000 equity grant (1,230 shares at $16.25) and $60,000 annual retainer; committee membership retainer $2,500; chair retainers: Board $30,000, Audit $15,000, Compensation $10,000 .
- FY2025: 1,193 shares awarded per director based on $16.76 price; same cash retainer and committee fees .
Compensation Structure Analysis
- Cash vs equity mix: CEO compensation primarily fixed salary; small equity component via director stock awards; no cash bonuses or long-term incentive plans at FREIT level .
- Shift in instruments: Stock options are currently none outstanding as of FY2024; equity grants have been direct-share awards to directors; prior broad option exercise in 2022 after exercise price adjustment tied to extraordinary distribution (now fully exercised/expired) .
- Guaranteed vs at-risk pay: CEO pay is largely fixed; compensation is not dependent on specific financial metrics; Compensation Committee considers overall performance qualitatively .
- Clawback: Policy to recover incentive-based compensation in case of restatement; relevant if future incentive comp is adopted .
Related Party Transactions
- External management: Hekemian & Co. manages all FREIT properties and receives management, leasing, mortgage origination, and other fees; FY2024 total approx. $2,003,000 (mgmt ~$1,351,000; other fees ~$652,000) .
- Joint ventures with affiliates: Westwood Hills paid ~$274,000 in management fees; Wayne PSC paid ~$136,000 in management fees and ~$5,000 in leasing commissions to Hekemian & Co. in FY2024 .
- Legacy Rotunda venture loans: FREIT advanced equity capital via Rotunda Notes to Hekemian & Co. employees/family entities; all repaid after Rotunda sale; no outstanding principal/interest remaining by FY2022 .
- Legal services: Secretary/Director John A. Aiello’s law firm received $243,219 in FY2024; he paid his $50,000 retainer to the firm .
- Valley National Bancorp loan: FREIT extended Westwood Plaza mortgage multiple times through May 1, 2025; arm’s-length terms; CEO Hekemian formerly Oritani director prior to Oritani’s merger into Valley .
Performance & Track Record
Financial performance (GAAP):
| Metric | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Total revenue ($000) | $31,271 | $28,344 | $28,678 |
| Net income attributable to common equity ($000) | $45,992 | $760 | $15,852 |
| Basic EPS ($) | $6.52 | $0.10 | $2.13 |
TSR and pay-versus-performance:
| Metric | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Value of $100 investment based on TSR ($) | $124.62 | $130.77 | $140.51 |
| PEO “Compensation Actually Paid” ($) | $830,779 | $643,644 | $680,000 |
| Net income ($000) | $69,244 | $(575) | $16,933 |
Operational notes:
- FY2024 results include net litigation settlement income of $15.673 million, boosting net income; segment NOI was $15.051 million; average residential occupancy 96.1%, commercial 50.9% .
- FY2023 decline reflected impact from prior property sales and occupancy changes .
Say-on-Pay & Shareholder Feedback
- 2023 advisory vote on executive compensation approved with approximately 74.6% of votes cast; next triennial say-on-pay expected at 2026 annual meeting .
Board Service History and Dual-Role Implications
- Hekemian holds dual roles as CEO/President and Director; he is also CEO and 33.3% equity holder of Hekemian & Co., FREIT’s external manager, which raises independence considerations and potential conflicts mitigated through independent committees and Audit Committee oversight of related-party transactions .
- Chairman is independent (Artinian), separating board leadership from management; no formal Lead Independent Director, but Chairman serves similar function informally .
- Committee composition is fully independent; attendance thresholds met .
Risk Indicators & Red Flags
- Share pledging: 78,917 shares pledged as collateral by Hekemian—a governance red flag for potential forced selling risk .
- External management fees and family affiliations: Significant related-party transactions with Hekemian & Co.; management agreement termination fee (including 2.5× multiplier upon merger/acquisition) can impact change-of-control outcomes .
- No Audit Committee Financial Expert under SEC definition, though members possess relevant attributes .
- Family relationship on board: Robert S. Hekemian, Jr. and David B. Hekemian are siblings; both have interests in Hekemian & Co. .
- Options repricing/adjustment occurred tied to extraordinary distribution in 2022 followed by large option exercises; currently no outstanding options .
Compensation Committee Analysis
- Committee: David F. McBride (Chair), Justin F. Meng, Richard J. Aslanian; one meeting held in FY2024 .
- No use of external compensation consultants disclosed; compensation philosophy emphasizes fixed pay with equity alignment via the Equity Incentive Plan; risk assessment indicates program does not encourage excessive risk .
Equity Ownership & Director Compensation Guidelines
- Director stock awards annually in lieu of $20,000 cash; retainer and chair fees as disclosed; total FY2024 director cash retainer paid $462,500 and $140,000 in stock awards across directors .
- Stock ownership guidelines for executives/directors not disclosed; hedging prohibited; pledging occurs and is disclosed .
Employment Contracts, Severance & Change-of-Control Economics
- Executives have no employment contracts with FREIT; no severance multiples or cash change-in-control payments at executive level .
- Equity plan accelerates vesting upon change in control; Board may set award terms including vesting and term up to 10 years .
- External manager (Hekemian & Co.) has termination fee and enhanced fee upon merger/acquisition; auto-renews; termination mechanics disclosed .
Investment Implications
- Alignment: CEO’s 4.9% beneficial ownership and annual equity awards suggest alignment, but pledging of 78,917 shares introduces forced-sale risk during market stress . The prohibition on hedging reduces misalignment risk .
- Incentive structure: Absence of incentive-based cash bonuses and performance-metric-linked equity reduces pay-for-performance signaling; qualitative consideration by the Compensation Committee means limited direct trading signals from comp outcomes .
- External manager economics: Material related-party fees to Hekemian & Co. and robust termination provisions could influence strategic decisions around asset sales or corporate actions; diligence on fee sustainability and committee oversight is key .
- Track record: FY2024 net income buoyed by litigation settlement; operational NOI steady; TSR trend improved to $140.51 vs $100 baseline over three-year disclosure, supporting shareholder returns despite mixed operating headwinds in commercial occupancy .